PCM
COV

Prelude Capital Management’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Prelude Capital Management’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-121,600
Closed -$12.4M – 2444
2014
Q4 		$12.4M Buy
121,600
+19,527
+19% +$1.87M 1.82% 1
2014
Q3 		$8.83M Buy
102,073
+72,458
+245% +$6.42M 1.24% 2
2014
Q2 		$2.67M Buy
29,615
+18,100
+157% +$1.35M 0.35% 43
2014
Q1 		$848K Buy
11,515
+3,195
+38% +$223K 0.11% 228
2013
Q4 		$567K Sell
8,320
-50
-0.6% -$3.25K 0.09% 306
2013
Q3 		$510K Sell
8,370
-3,666
-30% -$224K 0.08% 290
2013
Q2 		$671K Buy
+12,036
New +$696K 0.14% 185

Prelude Capital Management's COV Position: Q1 2015 in Review

Prelude Capital Management sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 121,600 shares — an estimated $12.4M sold.

Prelude Capital Management first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $12.4M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Prelude Capital Management reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Prelude Capital Management sold 121,600 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $12.4M.
  • Prelude Capital Management first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Prelude Capital Management's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $12.4M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Prelude Capital Management's 13F filing for Q1 2015, filed 15 May 2015.